跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Trokendi XR - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Trokendi XR
Approved
STANDARD
Trokendi XR
Orient Pharma Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cd5fb83ae9c1b562
Company
Orient Pharma Co., Ltd.
Type
Standard
Approval Details
Approval Id
cd5fb83ae9c1b562
Drug Approval Philippines Name
Trokendi XR
Product Name
Trokendi XR
Registration Number
DR-XY48231
Brand Name
Trokendi XR
Generic Name
Topiramate
Dosage Form
Extended Release Capsule
Dosage Strength
50 mg
Manufacturer
Orient Pharma Co., Ltd.
Importer
OEP Philippines, Inc.
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/orient-pharma-co-ltd
Issuance Date
27 July 2022
Expiry Date
27 July 2025
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cd5fb83ae9c1b562
Type
Standard
Back to Philippines FDA Approvals